Literature DB >> 2496903

Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.

S Molloi1, R Mazess, H Bendsen, M Wilson.   

Abstract

A collimated whole-body counter was used to measure the retention and distribution of radioactivity along the longitudinal axis of the body at several times during the 24 hours after the intravenous injection of 50 microCi of Tc-99m-diphosphonates. Whole-body retention (WBR) was measured together with regional uptakes in the following four areas: head, chest, bladder, and legs using two structurally related Tc-99m-diphosphonate skeletal imaging agents: 1-hydroxyethylidene diphosphonate (HEDP) and methylene diphosphonate (MDP). The average 24 hour WBR values in young males, reflecting skeletal uptake of these tracers, were 17.7 +/- 2.2% (n = 20) and 31.0 +/- 2.4% (n = 3), respectively. A model of skeletal clearance was developed using the sum of two exponentials. In normal volunteers the initial rapid clearance phase of both tracers had a half-time of about 1 hour, whereas the slower second phase clearance had a half-time of 22 hours with HEDP and 44 hours with MDP. The WBR is usually calculated for the entire body only at 24 hours, but with the improved spatial resolution of a collimated whole-body counter, regional measurements could potentially be done over shorter periods (6-8 hours) in order to simplify the procedure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496903     DOI: 10.1007/bf02556311

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  14 in total

1.  99mTc-MDP retention in osteoporosis: relationship to other indices of bone cell activity and response to calcium and vitamin D therapy.

Authors:  M W Davie; J M Britton; M Haddaway; I W McCall
Journal:  Eur J Nucl Med       Date:  1987

2.  Assessment of skeletal uptake of 99mTc-diphosphonate over a five day period.

Authors:  I Fogelman; W Martin
Journal:  Eur J Nucl Med       Date:  1983

3.  Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate.

Authors:  I Fogelman; R G Bessent; G Beastall; I T Boyle
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

4.  Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism.

Authors:  L Hyldstrup; N Mogensen; G F Jensen; P McNair; I Transbøl
Journal:  Scand J Clin Lab Invest       Date:  1984-04       Impact factor: 1.713

5.  Determination of bone turnover by urinary excretion of 99mTc-MDP.

Authors:  K Thomsen; L Nilas; T Mogensen; C Christiansen
Journal:  Eur J Nucl Med       Date:  1986

6.  A simplified technique for quantifying 24-h whole body retention of 99mTc-labeled methylene diphosphonate (MDP).

Authors:  F P Castronovo; K A McKusick; J Dann; G R Prout; H W Strauss
Journal:  Int J Nucl Med Biol       Date:  1985

7.  Quantitative radionuclide scanning in metabolic bone disease.

Authors:  H Meindok; A Rapoport; D G Oreopoulos; S Rabinovich; H E Meema; S Meema
Journal:  Nucl Med Commun       Date:  1985-03       Impact factor: 1.690

8.  Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.

Authors:  W Martin; I Fogelman; R G Bessent
Journal:  J Nucl Med       Date:  1981-06       Impact factor: 10.057

9.  Regional measurement of bone calcium accretion rate and exchangeable pool with a whole-body counter: method and studies in subjects without bone disease.

Authors:  P Bergmann; T Paternot; A Schoutens
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

10.  Whole body and regional retention of 99mTc-labeled pyrophosphate at 24 hours: physiological basis of the method for assessing the metabolism of bone in disease.

Authors:  P Martin; A Schoutens; D Manicourt; P Bergmann; M Fuss; M Verbanck
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.